Ahmadul Kadir
Huddinge, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Age, Frailty, and Comorbidity as Prognostic Factors for Short-Term Outcomes in Patients With Coronavirus Disease 2019 in Geriatric Care.
Journal: Journal of the American Medical Directors Association
Published: June 30, 2020
Clinical impact of 18F-FDG-PET among memory clinic patients with uncertain diagnosis.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 22, 2020
CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease.
Journal: Frontiers in molecular neuroscience
Published: June 04, 2019
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.
Journal: Alzheimer's research & therapy
Published: March 07, 2016
Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.
Journal: Journal of Alzheimer's disease : JAD
Published: September 25, 2015
Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case.
Journal: Neurocase
Published: December 16, 2014
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 25, 2014
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders
Published: December 21, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026